Correlations between oxidative DNA damage, oxidative stress and coenzyme Q10 in patients with coronary artery disease

International Journal of Medical Sciences

Volumn 9, Issue 8, 2012, Pages 621-626

  Kaya, Yüksel ^a   Çeb, AyşegülI ^b   Söylemez, Nihat ^a   Dem, Halitir ^c   Alp, Hamit Hakan ^d   Bakan, Ebubekir ^d  

^a KAFKAS UNIVERSITY   (Turkey)

^b GIRESUN UNIVERSITY   (Turkey)

^c YUZUNCU YIL UNIVERSITY   (Turkey)

^d ATATURK UNIVERSITY   (Turkey)

Author keywords

8 hydroxy 2' deoxyguanosine; An tioxidants; CoenzymeQ10; Coronary artery disease; Malondialdehyde; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DEOXYGUANOSINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UBIDECARENONE;

ADULT; ARTICLE; BLOOD SAMPLING; COLORIMETRY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA DAMAGE; DNA ISOLATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; SPECTROPHOTOMETRY;

CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY ARTERY DISEASE; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; UBIQUINONE;

EID: 84867564379     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.4768     Document Type: Article

References (37)

1. Yusoff K. Vitamin E in cardiovascular disease: has the die been cast? Asia Pac J Clin Nutr. 2002;11:443-447.
2. Kagan A, Kannel WB, Dawber TR, Revotskie N. The Coronary Profile. Ann N Y Acad Sci. 1963;97:883-894.
3. Demirbag R, Yilmaz R, Kocyigit A. Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat Res. 2005;570:197-203.
4. Andreassi MG, Botto N, Cocci F, Battaglia D, Antonioli E, Masetti S, Manfredi S, Colombo MG, Biagini A, Clerico A. Methylenetetrahydro-folate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet. 2003;112:171-177.
5. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-26.
6. Tas F, Hansel H, Belce A, Ilvan S, Argon A, Camlica H, Topuz E. Oxida-tive stress in breast cancer. Med Oncol. 2005;22:11-15.
7. Priya VV, Surapaneni KM. Erythrocyte lipid peroxidation, glutathione, ascorbic acid, vitamin E, antioxidant enzymes and serum homocysteine levels in patients with coronary artery disease. Journal of Clinical and Diagnostic Research 2008;2:1180-1185.
8. Mogadam RAP, Nemati A, Baghi AN. Serum MDA as a Diagnostic's Biomarker in Stable Coronary Heart Disease. Research Journal of Bio-logical Sciences. 2008;3:206-210.
9. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 1994;344:721-724.
10. Beckman KB, Ames BN. Oxidative decay of DNA. J Biol Chem. 1997; 272:19633-19636.
11. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res. 1997; 387:147-163.
12. Ernster L, Dallner G. Biochemical, physical and medical aspects of ubiq-uinone functions. Biochim Biophys Acta 1995;1271:195-204.
13. Crane F, Sun IL, Sun EE: The essential function of coenzyme Q10. Clin Invest 1993;71:55-59.
14. Stocker R, Bowry VM, Frei B: Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does al-pha-tocopherol. Proc Natl Acad Sci USA 1991;88:1646-1650.
15. Yamashita S, Yamamoto Y: Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Bio-chem 1997;250:66-73.
16. Khrosrow A, Godwin O. Rapid Purification of Human DNA from Whole Blood for Potential Application in Clinical Chemistry Laboratories. Clin Chem 1990;36:261-264.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;11:1215.
18. Shigenaga MK, Aboujaoude EN, Chen Q & Ames BN. Assays of oxida-tive DNA damage biomarkers 8-oxo-2'-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fuids by high-performance liquid chomatography with electrochemical detection. Methods Enzy-mol 1994; 234:16-33.
19. Khoschsorur GA, Winklhofer-Roob BM, Rabl H, Auer Th, Peng Z, Schaur RJ. Evaluation of a Sensitive HPLC Method for the Determination of Malondialdehyde, and Application of the Method to Different Bio-logical Materials. Chromatographia. 2000;52:181-184.
20. Armstrong D. Free radical and antioxidant protocols. Introduction. Methods Mol Biol. 1998;108:5-8.
21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-169.
22. Mosca F, Fattorini D, Bompadre S, Littarru GP. Assay of coenzyme Q(10) in plasma by a single dilution step. Anal Biochem. 2002;305:49-54.
23. Tomasetti M, Alleva R, Solenghi MD, et al. Distribution of antioxidants among blood components and lipoproteins: significance of li-pids/CoQ10 ratio as a possible marker of increased risk for atheroscle-rosis. Biofactors 1999;9:231-40.
24. Ari E, Kaya Y, Demir H, Cebi A, Alp HH, Bakan E, Odabasi D, Keskin S. Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients. Hemodial Int. 2011; 15: 453-459.
25. Botto N, Masetti S, Petrozzi L, Vassalle C, Manfredi S, Biagini A, An-dreassi MG. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis. 2002;13:269-274.
26. Raharjo S, Sofos JN, Schmidt GR. Solid-phase acid extraction improves thiobarbituric acid methods to determine lipid oxidation. J Food Sci. 1993;58:921-924.
27. Belch JJ, Mackay IR, Hill A, Jennings P, McCollum P. Oxidative stress is present in atherosclerotic peripheral arterial disease and further in-creased by diabetes mellitus. Int Angiol. 1995;14:385-388.
28. Pezeshkian M, Nouri M, Zahraei M, Afrasiabi A, Abadi NA. Study of MDA, antioxidant vitamins, lipoproteins serum levels and anthropome-try parameters in coronary artery disease patients. Medical Journal of Islamic Academy of Sciences. 2001;14:5-8.
29. Cebi A, Kaya Y, Gungor H, Demir H, Yoruk IH, Soylemez N, Gunes Y, Tuncer M. Trace elements, heavy metals and vitamin levels in patients with coronary artery disease. Int J Med Sci. 2011; 8(6): 456-60.
30. Sies H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91:31-38.
31. Cotgreave IA, Moldéus P, Orrenius S. Host biochemical defense mecha-nisms against prooxidants. Annu Rev Pharmacol Toxicol. 1988;28:189-212.
32. Artuch R, Salviati L, Jackson S, et al. Coenzyme Q10 deficiencies in neuromuscular diseases. Adv Exp Med Biol. 2009; 652:117-128.
33. Langsjoen PH, Langsjoen PH, Folkers K. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiol. 1990;65(7):521-3.
34. Mabuchi H, Higashikata T, Kawashiri M, Katsuda S, Mizuno M, Nohara A, Inazu A, Koizumi J, Kobayashi J. Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic pa-tients. J Atheroscler Thromb. 2005;12(2):111-9.
35. Berman M, Erman A, Ben-Gal T, Dvir D, Georghiou GP, Stamler A, Vered Y, Vidne BA, Aravot D. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, place-bo-controlled study. Clin Cardiol. 2004;27:295-299.
36. Singh RB, Wander GS, Rastogi A, Shukla PK, Mittal A, Sharma JP, Mehrotra SK, Kapoor R, Chopra RK. Randomized, double-blind place-bo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther. 1998;12:347-353.
37. Singh RB, Neki NS, Kartikey K, Pella D, Kumar A, Niaz MA, Thakur AS. Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem. 2003;246:75-82.